Latest News

Alzheimer's Disease Research

In this Issue

  • President’s Corner
  • New Blood Test Detects Unique Biomarker for Alzheimer’s
  • Researcher Spotlight: Kevin Beier, PhD
  • Medications That Can Mimic Dementia
  • Help Fight Alzheimer’s Through a Donor Advised Fund
Jan 10, 2024
National Glaucoma Research

January is Glaucoma Awareness Month, and BrightFocus Foundation is pleased to announce the 2024 schedule of Glaucoma Chats, free, accessible and interactive audio podcast conversations with leading glaucoma specialists and eye care professionals.

Jan 5, 2024
National Glaucoma Research

The U.S. Food and Drug Administration has approved a new treatment for glaucoma, iDose® TR (travoprost intracameral implant, 75 mcg). iDose TR is a first-of-its kind treatment that is designed to provide up to three years of 24/7, continuous drug therapy directly inside the eye, helping people with glaucoma take control over the elevated eye pressure associated with this vision disease.

Dec 15, 2023
Macular Degeneration Research

BrightFocus Foundation, in partnership with three other global vision loss advocacy organizations, has declared Dec. 5 as World Geographic Atrophy Day.

Dec 4, 2023
Alzheimer's Disease Research

In a new BrightFocus-funded study, researchers found an association between alterations in circadian rest-activity rhythms and risk of frailty incidence in older adults.

Nov 29, 2023
Alzheimer's Disease Research

BrightFocus Foundation’s Alzheimer’s Fast Track, an immersive workshop for early-career scientists, was held Nov. 8-10 in Washington, D.C. and convened 80 talented Alzheimer’s researchers from 19 U.S. states and six countries, including Japan, Spain, and Sweden.

Nov 17, 2023
Alzheimer's Disease Research

To achieve true health equity, we must ensure that all populations have equitable access to clinical trials and the benefits of medical research. With the right mix of resources, dedication, compassion, patience, and time, we can positively impact communities nationwide, write BrightFocus President and CEO Stacy Pagos Haller and board member Tonya M. Matthews, PhD, in a new op-ed.

Nov 13, 2023
National Glaucoma Research

In a first of its kind study, BrightFocus-funded researchers have identified a possible new way to improve drugs to treat glaucoma by studying a tiny part of the eye’s drainage system that plays a major role in eye pressure. 

Nov 13, 2023
Macular Degeneration Research

A potential drug rooted in initial grant funding from BrightFocus Foundation to Dr. Ilyas Washington gives hope to those suffering from Stargardt disease, a genetic form of macular degeneration.

Nov 9, 2023
BrightFocus Foundation

BrightFocus Foundation’s 2023 annual report highlights an incredible year of pioneering neurodegenerative research.  

Oct 30, 2023